Why the study?
Depressive symptoms are linked to increased mortality, but whether individual symptoms differ in their associations with mortality remains incompletely characterized.
Does higher depressive symptom burden increase mortality in a U.S. cohort?
Cohort (n=17,935)
Does higher depressive symptom burden increase mortality in a U.S. cohort?
Higher depressive symptom burden, particularly somatic symptoms and specific items like anhedonia and fatigue, is associated with increased all-cause mortality in a U.S. cohort.
Answers are grounded in this paper and cite their sources.
Individual PHQ-9 items showed differential mortality links; leaves open whether symptom-targeted approaches alter outcomes.
BACKGROUND: Depressive symptoms are associated with increased mortality, but whether individual symptoms differ in their associations with mortality remains incompletely characterized. METHODS: A prospective analysis of U.S. National Health and Nutrition Examination Survey data linked to mortality follow-up through 2019 examined PHQ-9 total score, affective and somatic domains, and individual items in relation to all-cause, heart disease, and non-cardiac mortality using survey-weighted Cox models. Item-level analyses were exploratory and adjusted for multiple comparisons. RESULTS: Among 17,935 participants, 885 deaths occurred. Each 1-point increase in PHQ-9 total score was associated with higher all-cause mortality (hazard ratio [HR], 1.036; 95% confidence interval [CI], 1.012-1.061; P=.003). When affective and somatic domains were modeled simultaneously, only the somatic domain remained modestly associated with all-cause mortality (HR, 1.044; 95% CI, 1.003-1.087; P=.037). In separate item analyses, anhedonia (HR, 1.256), fatigue (HR, 1.215), appetite or weight disturbance (HR, 1.175), and thoughts of death or self-harm (HR, 1.477) were associated with all-cause mortality after false discovery rate correction (adjusted P≤.014). In the mutually adjusted model, anhedonia (HR, 1.20), fatigue (HR, 1.21), and thoughts of death or self-harm (HR, 1.51) remained associated. Item-level models improved in-sample fit (likelihood-ratio P=.001) but minimally improved discrimination (ΔC-index=0.001). CONCLUSIONS: Higher depressive symptom burden was associated with all-cause mortality. Exploratory analyses suggested symptom-level heterogeneity, but item-level modeling did not meaningfully improve discrimination; symptom-specific findings require independent replication.
No takes yet. Share an insight, caveat, or question.
Ze Jin (2026) conducted a cohort in Depressive symptoms (n=17,935). Depressive symptoms (PHQ-9 score) was evaluated on all-cause mortality (HR 1.036, 95% CI 1.012-1.061, p=.003).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: